Literature DB >> 31810881

Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes.

Tsukasa Nabekura1, Luke Riggan2, Andrew D Hildreth2, Timothy E O'Sullivan3, Akira Shibuya4.   

Abstract

Although type 1 innate lymphoid cells (ILC1s) have been originally found as liver-resident ILCs, their pathophysiological role in the liver remains poorly investigated. Here, we demonstrated that carbon tetrachloride (CCl4) injection into mice activated ILC1s, but not natural killer (NK) cells, in the liver. Activated ILC1s produced interferon-γ (IFN-γ) and protected mice from CCl4-induced acute liver injury. IFN-γ released from activated ILC1s promoted the survival of hepatocytes through upregulation of Bcl-xL. An activating NK receptor, DNAM-1, was required for the optimal activation and IFN-γ production of liver ILC1s. Extracellular adenosine triphosphate accelerated interleukin-12-driven IFN-γ production by liver ILC1s. These findings suggest that ILC1s are critical for tissue protection during acute liver injury.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; Bcl-xL; CCl(4); DNAM-1; IFN-γ; IL-12; IL-7; ILC1; acute liver injury; hepatocyte

Mesh:

Substances:

Year:  2019        PMID: 31810881      PMCID: PMC8108607          DOI: 10.1016/j.immuni.2019.11.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  65 in total

1.  Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Authors:  Hui Peng; Xiaojun Jiang; Yonglin Chen; Dorothy K Sojka; Haiming Wei; Xiang Gao; Rui Sun; Wayne M Yokoyama; Zhigang Tian
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

2.  Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes.

Authors:  Laura K Mackay; Martina Minnich; Natasja A M Kragten; Yang Liao; Benjamin Nota; Cyril Seillet; Ali Zaid; Kevin Man; Simon Preston; David Freestone; Asolina Braun; Erica Wynne-Jones; Felix M Behr; Regina Stark; Daniel G Pellicci; Dale I Godfrey; Gabrielle T Belz; Marc Pellegrini; Thomas Gebhardt; Meinrad Busslinger; Wei Shi; Francis R Carbone; René A W van Lier; Axel Kallies; Klaas P J M van Gisbergen
Journal:  Science       Date:  2016-04-22       Impact factor: 47.728

Review 3.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

4.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells.

Authors:  K Takeda; Y Hayakawa; M J Smyth; N Kayagaki; N Yamaguchi; S Kakuta; Y Iwakura; H Yagita; K Okumura
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

5.  Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor.

Authors:  Emilie Narni-Mancinelli; Julie Chaix; Aurore Fenis; Yann M Kerdiles; Nadia Yessaad; Ana Reynders; Claude Gregoire; Herve Luche; Sophie Ugolini; Elena Tomasello; Thierry Walzer; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-21       Impact factor: 11.205

Review 6.  Regulation of hepatocyte fate by interferon-γ.

Authors:  Christopher J Horras; Cheri L Lamb; Kristen A Mitchell
Journal:  Cytokine Growth Factor Rev       Date:  2011-02-18       Impact factor: 7.638

Review 7.  Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.

Authors:  D L Donnelly-Roberts; M F Jarvis
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

8.  Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens.

Authors:  Theresa L Geiger; Michael C Abt; Georg Gasteiger; Matthew A Firth; Margaret H O'Connor; Clair D Geary; Timothy E O'Sullivan; Marcel R van den Brink; Eric G Pamer; Alan M Hanash; Joseph C Sun
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

Review 9.  Type 1 Innate Lymphoid Cell Biology: Lessons Learnt from Natural Killer Cells.

Authors:  Yuhao Jiao; Nicholas D Huntington; Gabrielle T Belz; Cyril Seillet
Journal:  Front Immunol       Date:  2016-10-12       Impact factor: 7.561

10.  Accelerated tumor growth in mice deficient in DNAM-1 receptor.

Authors:  Akiko Iguchi-Manaka; Hirayasu Kai; Yumi Yamashita; Kai Shibata; Satoko Tahara-Hanaoka; Shin-ichiro Honda; Teruhito Yasui; Hitoshi Kikutani; Kazuko Shibuya; Akira Shibuya
Journal:  J Exp Med       Date:  2008-11-24       Impact factor: 14.307

View more
  20 in total

1.  CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells.

Authors:  Luke Riggan; Andrew D Hildreth; Marion Rolot; Yung-Yu Wong; William Satyadi; Ryan Sun; Christopher Huerta; Timothy E O'Sullivan
Journal:  Cell Rep       Date:  2020-05-19       Impact factor: 9.423

Review 2.  Innate and Innate-like Effector Lymphocytes in Health and Disease.

Authors:  Luc Van Kaer; J Luke Postoak; Wenqiang Song; Lan Wu
Journal:  J Immunol       Date:  2022-07-15       Impact factor: 5.426

3.  Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.

Authors:  Jiman Kang; Jedson R Liggett; Digvijay Patil; Suman Ranjit; Katrina Loh; Anju Duttargi; Yuki Cui; Kesha Oza; Brett S Frank; DongHyang Kwon; Bhaskar Kallakury; Simon C Robson; Thomas M Fishbein; Wanxing Cui; Khalid Khan; Alexander Kroemer
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 4.  Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.

Authors:  Benjamin Ruf; Bernd Heinrich; Tim F Greten
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

Review 5.  Antiviral Activities of Group I Innate Lymphoid Cells.

Authors:  Ramon A Lujan; Sophia M Vrba; Heather D Hickman
Journal:  J Mol Biol       Date:  2021-09-22       Impact factor: 5.469

6.  Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.

Authors:  Adelle P McFarland; Adam Yalin; Shuang-Yin Wang; Victor S Cortez; Tomer Landsberger; Raki Sudan; Vincent Peng; Hannah L Miller; Biancamaria Ricci; Eyal David; Roberta Faccio; Ido Amit; Marco Colonna
Journal:  Immunity       Date:  2021-05-03       Impact factor: 43.474

Review 7.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

8.  Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis.

Authors:  Laura Ducimetière; Giulia Lucchiari; Gioana Litscher; Marc Nater; Laura Heeb; Nicolás Gonzalo Nuñez; Laura Wyss; Dominik Burri; Marijne Vermeer; Julia Gschwend; Andreas E Moor; Burkhard Becher; Maries van den Broek; Sonia Tugues
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

Review 9.  The role of natural killer cells in liver inflammation.

Authors:  A J Highton; I S Schuster; M A Degli-Esposti; M Altfeld
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

10.  Local tissue development of type 1 innate lymphoid cells: guided by interferon-gamma.

Authors:  Thomas M Conlon; Percy A Knolle; Ali Önder Yildirim
Journal:  Signal Transduct Target Ther       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.